BioGene Therapeutics
Biotechnology company with a recent SEC Form D offering.
Biotech
📍 AUSTIN, TEXAS
Current Valuation
Private
PRIVATE
Biotechnology company headquartered in AUSTIN, TEXAS. Filed SEC Form D on 20260723 for a $4.5M Regulation D offering.
Company Profile
Growth
Filed SEC Form D on 20260723 for $4.5M Regulation D offering
Last Round
Form D filing — $5M (Invalid Date)
Fundraising Status
Form D filing · $5M
privateTotal raised $5M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $5M | Invalid Date | — | — |
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.